Keyphrases
Potential Contribution
100%
Clinical Outcomes
100%
Herpes Simplex Virus
100%
Neonatal Infection
100%
Virus Diseases
100%
Viral Genetic Diversity
100%
Neonatal Herpes
100%
Herpes Simplex Virus Type 1 (HSV-1)
50%
Herpes Simplex Virus 2 (HSV-2)
50%
Skin Lesions
50%
Antiretroviral Therapy
50%
Diagnostic Ratios
50%
Clinical Course
50%
Herpes Simplex Virus Infection
50%
Clinical Diagnostics
50%
Statistical Power
50%
Human Host
50%
Disseminated Infection
50%
Central Nervous System Infections
50%
Neonatal Outcome
50%
New Parents
50%
Clinical Impact
50%
Viral Spread
50%
Neonatal HSV Infection
50%
Medicine and Dentistry
Virus Infection
100%
Genetic Variability
100%
Herpes Simplex Virus
100%
Infection
66%
Newborn Infection
66%
Diagnosis
33%
Herpes Simplex Virus 2
33%
Human Alphaherpesvirus 1
33%
Disease Course
33%
Skin Defect
33%
Central Nervous System Infection
33%
Antiviral Therapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Virus Infection
100%
Herpes Simplex Virus
100%
Infection
66%
Herpes Simplex Virus 2
33%
Human Alphaherpesvirus 1
33%
Disease Course
33%
Skin Defect
33%
Antiviral Therapy
33%
Central Nervous System Infection
33%